Hepatitis B virus exposure in human immunodeficiency virus seropositive Cuban patients

Hepatitis B virus exposure in human immunodeficiency virus seropositive Cuban patients

In order to estimate the prevalence of serological markers of exposure to Hepatitis B Virus (HBV), 295 subjects were selected at random from the National Registry of human immunodeficiency virus positive subjects. Evidence of exposure to HBV was defined as: testing Hepatitis B surface antigen (HBsAg...

Full description

Bibliographic Details
Main Authors:	Licel Rodríguez, Fernando Collado-Mesa, Ulices Aragón, Belkis Díaz, Juan Rivero
Format:	Article
Language:	English
Published:	Fundação Oswaldo Cruz (FIOCRUZ) 2000-04-01
Series:	Memorias do Instituto Oswaldo Cruz
Subjects:	Hepatitis B Virus (HBV) Hepatitis B surface antigen (HBsAg) anti-Hepatitis B core antigen (HBc)
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762000000200019

Similar Items

Atypical Hepatitis B Virus Serology Profile—Hepatitis B Surface Antigen-Positive/Hepatitis B Core Antibody-Negative—In Hepatitis B Virus/HIV Coinfected Individuals in Botswana
by: Bonolo B. Phinius, et al.
Published: (2023-07-01)

Age-wise and Gender-wise Prevalence of Hepatitis B Virus (HBV) Infection in Lahore, Pakistan
by: Aqib Nazeer, et al.
Published: (2019-12-01)

Correlation between Results of Semi-Quantitative and Quantitative Tests for Hepatitis B Virus Surface Antigen among Patients Achieving Viral Suppression with Antiviral Treatment
by: Goh Eun Chung, et al.
Published: (2022-07-01)

Commentary: Serum hepatitis B virus large and medium surface proteins as novel tools for predicting HBsAg clearance
by: Maria Pfefferkorn, et al.
Published: (2022-12-01)

Persistence and risk factors of occult hepatitis B virus infections among antiretroviral therapy-naïve people living with HIV in Botswana
by: Motswedi Anderson, et al.
Published: (2024-05-01)

PREVALENCE OF HEPATITIS B VIRUS INFECTION IN YOUNG STUDENTS OF ANAND
by: Shilpa N Supekar, et al.
Published: (2012-09-01)

HBsAg protein composition and clinical outcomes in chronic hepatitis D and variations across HBeAg-negative chronic HBsAg carriers
by: Luisa Roade, et al.
Published: (2023-10-01)

Prevalence of Hepatitis B Serum Markers in Young Military Recruits in Greece: A Comparison Study between 2005 and 2019 Cohorts
by: Nikolaos Papadopoulos, et al.
Published: (2021-11-01)

HBsAg Loss as a Treatment Endpoint for Chronic HBV Infection: HBV Cure
by: Maryam Moini, et al.
Published: (2022-03-01)

SEROPOSITIVITY OF HEPATITIS B AND C AMONG SYRIAN MULTITRANSFUSED PATIENTS WITH HEMOGLOBINOPATHY
by: Widad Yazaji, et al.
Published: (2016-09-01)

Prevalence and Transfusion Risks of Occult Hepatitis B Infection Among HBcAb-Positive Blood Donors in a High-Endemic Region
by: Ahmed Subeh Alshrari, et al.
Published: (2025-02-01)

Kinetics of Hepatitis B Virus Load During Haemodialysis Sessions and α-Interferon: A Prospective Study
by: Fabrizio Fabrizi, et al.
Published: (2013-09-01)

Prevalence of occult hepatitis B virus infection and characterisation of hepatitis B surface antigen mutants among adults in western Croatia
by: Marina Bubonja-Šonje, et al.
Published: (2024-01-01)

A cross-sectional study on dental surgeons’ immune status against hepatitis B virus in the Public Health System
by: Clea Adas Saliba Garbin, et al.
Published: (2020-03-01)

Long-term hepatitis B surface antigen kinetics after nucleos(t)ide analog discontinuation in patients with noncirrhotic chronic hepatitis B
by: Lina Wu, et al.
Published: (2024-09-01)

Clinical outcomes of treatment-naïve HBeAg-negative patients with chronic hepatitis B virus infection with low serum HBsAg and undetectable HBV DNA
by: Jian Wang, et al.
Published: (2024-12-01)

Hepatitis B Virus Genotype H: Epidemiological, Molecular, and Clinical Characteristics in Mexico
by: Arturo Panduro, et al.
Published: (2023-10-01)

The effectiveness of hepatitis B vaccine in toddlers based on the five-year period national basic health research (Riskesdas 2007, 2013 and 2018) in Indonesia
by: Christina Safira Whinie Lestari, et al.
Published: (2023-05-01)

Correlation between quantitative HBsAg and quantitative HBV DNA in chronic hepatitis B patients: a systematic review and meta-analysis
by: Ummi Maimunah, et al.
Published: (2024-05-01)

A prospective study of hepatitis B virus markers in patients with chronic HBV infection from Brazilian families of Western and Asian origin
by: F.J. Carrilho, et al.
Published: (2005-09-01)

Occult HBV Infection in Patients Infected by HIV or HCV: Comparison between HBV-DNA and Two Assays for HBsAg
by: Silvia Meschi, et al.
Published: (2024-03-01)

Hepatitis B immunization status and risk factors of people aged 1 to 69 in Huangpu District, Shanghai, China
by: Yijun Wang, et al.
Published: (2023-12-01)

Hepatitis B virus surface antigen seroconversion in HIV-infected individual after pegylated interferon-alpha treatment: a case report
by: Adriane Maira Delicio, et al.
Published: (2013-12-01)

Silicon Nanowires Length and Numbers Dependence on Sensitivity of the Field-Effect Transistor Sensor for Hepatitis B Virus Surface Antigen Detection
by: Chi-Chang Wu
Published: (2022-02-01)

Prevalence and chemotherapy-induced reactivation of occult hepatitis B virus among hepatitis B surface antigen negative patients with diffuse large B-cell lymphoma: Significance of hepatitis B core antibodies screening
by: Tamer A. Elbedewy, et al.
Published: (2015-03-01)

Seroprevalence of HbsAg, anti-HBc and anti-HCV in Southern Brazil, 1999-2001
by: Rosini Nilton, et al.
Published: (2003-01-01)

Occult Hepatitis B in Patients Undergoing Chemotherapy
by: Alireza Saadat, et al.
Published: (2019-06-01)

Low prevalence of hepatitis delta infection in Cuban HBsAg carriers: Prospect for elimination
by: Licel de los Ángeles Rodríguez Lay, et al.
Published: (2023-02-01)

Current Challenges and Future Perspectives of Diagnosis of Hepatitis B Virus
by: Manoj Kumar, et al.
Published: (2023-01-01)

TREND IN SEROPREVALENCE OF HEPATITIS B VIRUS INFECTION AMONG BLOOD DONORS AT A TERTIARY CARE CENTRE OF RAJASTHAN, INDIA
by: Poojaba Jadeja, et al.
Published: (2014-09-01)

A Therapeutic Hepatitis B Virus DNA Vaccine Induces Specific Immune Responses in Mice and Non-Human Primates
by: Dorien De Pooter, et al.
Published: (2021-08-01)

Expresión y purificación del preS1/2 del virus de la hepatitis B (VHB) y su utilidad en el diagnóstico de la infección
by: Yismelvy Marquez, et al.
Published: (2013-12-01)

Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies
by: Lorenzo Piermatteo, et al.
Published: (2023-12-01)

Response predictors to treatment with pegylated interferon in chronic hepatitis B
by: Paulo Roberto Abrão Ferreira, et al.

Decreasing hepatitis B seroprevalence in pregnant women in Taiwan between 2016 and 2021: a claim-based cohort study
by: Li-Nien Chien, et al.
Published: (2025-01-01)

Analysis of long non-coding RNA (lncRNA) expression in hepatitis B patients
by: Sunde Yılmaz Susluer, et al.
Published: (2018-05-01)

Analytical Performance of the Sysmex HISCL HBsAg Assay and Comparison with the Roche Elecsys HBsAg II Quant Assay in the Quantification of Hepatitis B Surface Antigen
by: Joonhong Park, et al.
Published: (2021-11-01)

Clinical usefulness of an ultra-high-sensitivity hepatitis B surface antigen assay to determine the cessation of treatment for HBV reactivation
by: Takanori Suzuki, et al.
Published: (2025-01-01)

Viral hepatitis in patients infected with human immunodeficiency virus
by: Maria Helena P. Pavan, et al.

Chronic carriers of hepatitis B surface antigen in an endemic area for schistosomiasis mansoni in Brazil
by: JC Serufo, et al.
Published: (1998-01-01)